Cell Culture Media Market Overview
Market Research Future (MRFR) expects the cell culture media market to attain a valuation more than USD 4,337.83 million by the year 2027. Between 2020 and 2027, the market’s growth rate is projected to be 8.33%, estimates MRFR.
Top Boosters and Key Challenges
The cell culture media industry is thriving on the back of the rapid expansion of the pharmaceutical industry combined with the burgeoning pharma drug pipeline. Accelerated cancer cases coupled with the rise in various infectious disorders, along with the blossoming elderly populace would further add to the market worth. The increase in research activities have led to emergence of advanced drugs as well as therapies to help address the high burden of chronic ailments. These factors are presumed to give rise several lucrative opportunities for the cell culture media players in the ensuing years.
Emerging countries such as Brazil, India, and China are a few attractive destinations for the vendors specializing in stem cell cultures. These countries enjoy relatively lenient regulatory standards with respect to stem cell-based tests as well as a favorable business scenario. The launch of novel 3d cell culture methods and the mounting of these methods for vaccine and biopharmaceutical production will also enhance the market share. Various firms are entering acquisitions and mergers to enhance their product ranges, which is yet another factor that would foster the market growth in the years ahead.
Market Segmentation
The MRFR study has thoroughly analyzed the cell culture media industry and has profiled a few major segments for detailed understanding. Some of these segments include product type, application, as well as end user.
Top product types listed in the MRFR analysis include media, sera as well as reagents.
A few key applications of the cell culture media profiled in the report are gene therapy, biopharmaceutical, cytogenetic, tissue-culture and manufacturing, and others.
Primary end-users of cell culture media include biopharmaceutical companies, academic and research laboratories, hospitals and diagnostics centers, and many more.
Regional Outlook
The American market is currently prevailing as the top performer and would continue to retain its lead throughout the conjectured period. High spending on R&D activities by major pharmaceutical and biotech vendors, rising burden of chronic disorders and the resultant surge in the requirement for advanced drugs and vaccines also benefit the American market.
APAC could be the fastest progressing market for cell culture media in the following years, thanks to the escalating number of research institutes and the availability of lower-priced labor and manufacturing costs. Rapid upgradation of the healthcare infrastructure and American and European vendors making heavy investments in China and India will also work in favor of the regional industry.
Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/cell-culture-media-market-4462
Renowned Market Firms
The affluent market participants listed in the MRFR report include The Sartorius Group (Germany), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Bio-Rad Laboratories, Inc. (US), HiMedia Laboratories (India), Merck KGaA (Germany), PromoCell (Germany), Sera Scandia A/S (Denmark), and many more.
View all reports related to Healthcare Industry visit at: https://www.marketresearchfuture.com/categories/healthcare-market-report